Elanco · 2 days ago
Manufacturing Associate Intern (Summer 2026): Elwood, Kansas
Elanco is a global leader in animal health dedicated to innovation and delivering products and services for farm animals and pets. The Manufacturing Associate Intern will work within the TSMS team on a technical project for process improvement, focusing on understanding pharmaceutical manufacturing and engineering processes.
ManufacturingPetSupply Chain Management
Responsibilities
Understand the science of pharmaceutical manufacturing and engineering
Work within cross-functional teams to implement process improvements within a pharmaceutical space
Further understand the manufacturing process
Investigate ideas for cost-savings
Qualification
Required
Currently enrolled in Biology, Microbiology, Biochemistry, Chemistry with a Biology focus, Cell Biology, Chemical Engineering, or related engineering fields
Experience in Microsoft Excel, problem solving, and technical writing
A willingness to learn
Preferred
Have an interest in reviewing and improving processes, data, statistics, or materials science
Strong communication and interpersonal skills
Strong organizational and time management skills
Must be able to work exceptionally well independently and with minimal supervision
Benefits
Networking events
Assigned mentors
Professional development opportunities
Optional all-inclusive housing for $150 per week
Full time roles or additional internships for interns with outstanding performance
Company
Elanco
Elanco is an animal health company that manufactures and markets a diverse range of products to promote animal health and well-being.
H1B Sponsorship
Elanco has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (9)
Funding
Current Stage
Public CompanyTotal Funding
$252.86MKey Investors
AncoraBill & Melinda Gates Foundation
2023-12-30Post Ipo Equity· $250M
2018-09-19IPO
2017-05-24Grant· $2.86M
Leadership Team
Recent News
2026-01-03
2025-12-18
Company data provided by crunchbase